Marco Solmi1, Nicola Veronese2, Angela Favaro1, Paolo Santonastaso1, Enzo Manzato2, Giuseppe Sergi2, Christoph U Correll3. 1. Department of Neurosciences, University of Padova, Padova, Italy. 2. Department of Medicine-DIMED, Geriatrics Section, University of Padova, Padova, Italy. 3. The Zucker Hillside Hospital, Psychiatry Research, NorthShore-Long Island Jewish Health System, Glen Oaks, NY, USA; Hofstra North Shore LIJ School of Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Manhasset, NY, USA; Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: ccorrell@lij.edu.
Abstract
OBJECTIVE: Although inflammation is increasingly implicated in psychiatric disorders, less is known about its role in anorexia nervosa (AN), an illness with low body mass index (BMI). METHODS: We performed a systematic PubMed literature search until 12/31/2013 and meta-analyzed cross-sectional and longitudinal studies comparing circulating pro- and anti-inflammatory cytokines between patients with anorexia nervosa (AN) and healthy controls (HCs) (1) before and (2) after weight gain, and (3) within AN patients before and after weight gain. Standardized mean differences (SMDs)± 95% confidence intervals (CIs) for results from ≥ 2 studies were calculated. RESULTS: Of 999 initial hits, 22 studies with 924 participants (AN=512, HCs=412) were eligible. Compared to HCs, tumor necrosis factor (TNF)-alpha (SMD=0.35, 95%CI=0.09-0.61, p=0.008), interleukin (IL)1-beta (SMD=0.51, 95%CI=0.18-0.84, p=0.003), IL-6 (SMD=0.43, 95%CI=0.11-0.76, p=0.009), and TNF-receptor-II (SMD=0.42, 95%CI:0.07-0.78, p=0.02) were significantly elevated in AN, while C-reactive protein (SMD=-0.53, 95%CI=-.77, -0.28, p<0.0001) and IL-6 receptor (SMD=-0.85, 95%CI=-1.33, -0.36, p=0.0006) were significantly decreased. No differences were found for TNF-receptor I and TGF-β. Across a subset of eight longitudinal studies (AN=152, HCs=129), significant weight gain (baseline BMI=15.4 ± 1.5, endpoint BMI=18.2 ± 1.6, p<0.0001) was not associated with significant changes in TNF-α, IL-6 and IL1-β. However, after weight gain, IL-6 was not different anymore compared to HCs (SMD=0.06, 95%CI=-0.32, 0.45, p=0.75). In meta-regression, shorter illness duration (p=0.0008), but not younger age (p=0.71) significantly moderated greater IL-6 levels. CONCLUSION: Despite abnormally low BMI, AN seems to be associated with increased inflammatory cytokines. Whether specific elevated cytokines represent trait or state markers of AN, and whether they could be treatment targets requires further study.
OBJECTIVE: Although inflammation is increasingly implicated in psychiatric disorders, less is known about its role in anorexia nervosa (AN), an illness with low body mass index (BMI). METHODS: We performed a systematic PubMed literature search until 12/31/2013 and meta-analyzed cross-sectional and longitudinal studies comparing circulating pro- and anti-inflammatory cytokines between patients with anorexia nervosa (AN) and healthy controls (HCs) (1) before and (2) after weight gain, and (3) within AN patients before and after weight gain. Standardized mean differences (SMDs)± 95% confidence intervals (CIs) for results from ≥ 2 studies were calculated. RESULTS: Of 999 initial hits, 22 studies with 924 participants (AN=512, HCs=412) were eligible. Compared to HCs, tumor necrosis factor (TNF)-alpha (SMD=0.35, 95%CI=0.09-0.61, p=0.008), interleukin (IL)1-beta (SMD=0.51, 95%CI=0.18-0.84, p=0.003), IL-6 (SMD=0.43, 95%CI=0.11-0.76, p=0.009), and TNF-receptor-II (SMD=0.42, 95%CI:0.07-0.78, p=0.02) were significantly elevated in AN, while C-reactive protein (SMD=-0.53, 95%CI=-.77, -0.28, p<0.0001) and IL-6 receptor (SMD=-0.85, 95%CI=-1.33, -0.36, p=0.0006) were significantly decreased. No differences were found for TNF-receptor I and TGF-β. Across a subset of eight longitudinal studies (AN=152, HCs=129), significant weight gain (baseline BMI=15.4 ± 1.5, endpoint BMI=18.2 ± 1.6, p<0.0001) was not associated with significant changes in TNF-α, IL-6 and IL1-β. However, after weight gain, IL-6 was not different anymore compared to HCs (SMD=0.06, 95%CI=-0.32, 0.45, p=0.75). In meta-regression, shorter illness duration (p=0.0008), but not younger age (p=0.71) significantly moderated greater IL-6 levels. CONCLUSION: Despite abnormally low BMI, AN seems to be associated with increased inflammatory cytokines. Whether specific elevated cytokines represent trait or state markers of AN, and whether they could be treatment targets requires further study.
Authors: Sai Polineni; Megi Resulaj; Alexander T Faje; Erinne Meenaghan; Miriam A Bredella; Mary Bouxsein; Hang Lee; Ormond A MacDougald; Anne Klibanski; Pouneh K Fazeli Journal: J Bone Miner Res Date: 2020-03-23 Impact factor: 6.741
Authors: Montserrat Graell; Patricia de Andrés; Ana Rosa Sepúlveda; Alba Moreno; Ángel Villaseñor; Mar Faya; Carmen Martínez-Cantarero; Sonia Gómez-Martínez; Ascensión Marcos; Gonzalo Morandé; Esther Nova Journal: Int J Methods Psychiatr Res Date: 2018-08-21 Impact factor: 4.035
Authors: Alberto Rodríguez-Quiroga; Karina S MacDowell; Juan C Leza; José Luis Carrasco; Marina Díaz-Marsá Journal: Eat Weight Disord Date: 2020-05-18 Impact factor: 4.652
Authors: Nicola Veronese; Ai Koyanagi; Brendon Stubbs; Marco Solmi; Michele Fornaro; Brisa S Fernandes; Christoph Mueller; Trevor Thompson; André F Carvalho; Stefania Maggi Journal: Int J Geriatr Psychiatry Date: 2017-08-06 Impact factor: 3.485
Authors: Allison Stumper; Daniel P Moriarity; Christopher L Coe; Lauren M Ellman; Lyn Y Abramson; Lauren B Alloy Journal: J Youth Adolesc Date: 2019-08-13
Authors: Lauren Breithaupt; Ole Köhler-Forsberg; Janne Tidselbak Larsen; Michael E Benros; Laura Marie Thornton; Cynthia M Bulik; Liselotte Petersen Journal: JAMA Psychiatry Date: 2019-08-01 Impact factor: 21.596